Cadrenal Therapeutics, Inc. Common Stock (CVKD) Stock Price History
Historical prices from 2023 to 2026
Loading 10-year price history...
CVKD Historical Performance
Short-Term Returns
CVKD Stock Price Trajectory (2023–2026)
As of May 8, 2026, Cadrenal Therapeutics, Inc. Common Stock (CVKD) trades at $6.02, representing a -63.0% return over the past year. The stock has delivered a -90.3% total return over five years (-37.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $101.25 on January 20, 2023. From this peak, CVKD has corrected -94.1%, currently trading 37% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers PTGX (+129.4% 1Y), TCRX (-11.0% 1Y), and NKTR (+818.2% 1Y), CVKD has underperformed the peer group average. Compare CVKD vs PTGX →
CVKD Historical Price Data (2025–2026)
Showing 30 of 828 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 6.19 | 6.50 | 5.85 | 6.02 | 55K | -2.43% |
| 2026-05-06 | 5.76 | 6.54 | 5.69 | 6.17 | 90K | -2.37% |
| 2026-05-05 | 6.61 | 6.74 | 6.31 | 6.32 | 103K | -4.39% |
| 2026-05-04 | 6.47 | 6.96 | 6.30 | 6.61 | 56K | +4.09% |
| 2026-05-01 | 6.84 | 7.18 | 6.16 | 6.35 | 127K | -4.80% |
| 2026-04-30 | 5.47 | 6.67 | 5.44 | 6.67 | 112K | +19.32% |
| 2026-04-29 | 5.53 | 5.79 | 5.35 | 5.59 | 54K | +4.88% |
| 2026-04-28 | 5.70 | 5.91 | 5.19 | 5.33 | 48K | -6.49% |
| 2026-04-27 | 5.57 | 5.90 | 5.51 | 5.70 | 46K | +3.64% |
| 2026-04-24 | 5.50 | 5.86 | 5.35 | 5.50 | 33K | -0.54% |
| 2026-04-23 | 5.84 | 5.96 | 5.32 | 5.53 | 51K | -5.63% |
| 2026-04-22 | 5.70 | 6.09 | 5.39 | 5.86 | 55K | +8.92% |
| 2026-04-21 | 5.21 | 5.91 | 5.21 | 5.38 | 95K | +2.48% |
| 2026-04-20 | 5.22 | 5.44 | 5.01 | 5.25 | 51K | -1.41% |
| 2026-04-17 | 4.96 | 6.05 | 4.81 | 5.33 | 189K | +9.79% |
| 2026-04-16 | 4.84 | 4.89 | 4.68 | 4.85 | 30K | +0.83% |
| 2026-04-15 | 4.80 | 4.90 | 4.70 | 4.81 | 26K | +0.42% |
| 2026-04-14 | 5.03 | 5.15 | 4.74 | 4.79 | 21K | -4.01% |
| 2026-04-13 | 4.72 | 5.00 | 4.51 | 4.99 | 16K | +4.83% |
| 2026-04-10 | 4.92 | 5.13 | 4.75 | 4.76 | 39K | -4.23% |
| 2026-04-09 | 4.81 | 5.07 | 4.66 | 4.97 | 15K | +2.47% |
| 2026-04-08 | 4.46 | 5.23 | 4.36 | 4.85 | 60K | +12.27% |
| 2026-04-07 | 4.50 | 4.57 | 4.25 | 4.32 | 28K | -4.21% |
| 2026-04-06 | 4.67 | 4.70 | 4.42 | 4.51 | 20K | -4.04% |
| 2026-04-02 | 4.71 | 4.81 | 4.59 | 4.70 | 14K | -4.08% |
| 2026-04-01 | 5.14 | 5.50 | 4.37 | 4.90 | 54K | -4.30% |
| 2026-03-31 | 4.33 | 5.17 | 4.32 | 5.12 | 53K | +20.47% |
| 2026-03-30 | 4.99 | 5.00 | 4.20 | 4.25 | 47K | -14.83% |
| 2026-03-27 | 5.01 | 5.08 | 4.92 | 4.99 | 26K | -6.90% |
| 2026-03-26 | 5.26 | 5.83 | 5.22 | 5.36 | 39K | -1.11% |
See CVKD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CVKD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CVKD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCVKD — Frequently Asked Questions
Quick answers to the most common questions about buying CVKD stock.
How has CVKD stock performed recently?
CVKD declined -63.0% over the past year, below its 5-year annualized CAGR of -37.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is CVKD's all-time high price?
Cadrenal Therapeutics, Inc. Common Stock reached $101.25 on 2023-01-20. The 52-week high is $16.50. Current 1-year return of -63.0% places the stock further from historical peaks.
Where can I download CVKD historical price data?
This page provides CVKD daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2023-2026, downloadable in CSV format.